Adezmapimod
Adezmapimod (PB 203580) is a p38 MAPK inhibitor (IC50: 0.3-0.5 μM). It shows more than 100-fold selectivity over PKB, LCK, and GSK-3β.
| Catalog Number | T1764 |
| Alternative Name(s) | PB 203580 , RWJ 64809 , SB203580 |
| Research Area | Autophagy|||MAPK |
| Molecular Formula | C21H16FN3OS |
| CAS# | 152121-47-6 |
| Purity | 99.79% |
| SMILES | CS(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccncc1)-c1ccc(F)cc1 |
| Size | 50 mg |
| Supplier Page | https://www.targetmol.com/compound/Adezmapimod |
| Additional Information | https://www.targetmol.com/datasheet/T1764 |